Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
8.47 USD | -0.12% | -4.10% | -0.36% |
12:33pm | Wedbush Adjusts Voyager Therapeutics' PT to $8 From $10, Keeps Neutral Rating | MT |
05-13 | Transcript : Voyager Therapeutics, Inc., Q1 2024 Earnings Call, May 13, 2024 |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-0.36% | 461M | |
+29.64% | 48.16B | |
-1.13% | 41.73B | |
+43.45% | 41.03B | |
-5.26% | 28.77B | |
+9.95% | 25.59B | |
-22.91% | 18.96B | |
+8.32% | 12.92B | |
+28.92% | 12.03B | |
-1.98% | 11.77B |
- Stock Market
- Equities
- VYGR Stock
- News Voyager Therapeutics, Inc.
- Transcript : Voyager Therapeutics, Inc., Q2 2023 Earnings Call, Aug 03, 2023